Short Interest in Principal Healthcare Innovators Index ETF (NASDAQ:BTEC) Decreases By 94.9%


Share on StockTwits

Principal Healthcare Innovators Index ETF (NASDAQ:BTEC) was the recipient of a significant decrease in short interest in the month of March. As of March 31st, there was short interest totalling 700 shares, a decrease of 94.9% from the March 15th total of 13,600 shares. Based on an average daily trading volume, of 25,800 shares, the short-interest ratio is presently 0.0 days.

Large investors have recently added to or reduced their stakes in the business. International Assets Investment Management LLC bought a new stake in Principal Healthcare Innovators Index ETF in the fourth quarter valued at approximately $30,000. Proequities Inc. increased its stake in shares of Principal Healthcare Innovators Index ETF by 15.5% during the fourth quarter. Proequities Inc. now owns 1,511 shares of the company’s stock worth $89,000 after purchasing an additional 203 shares during the period. Citigroup Inc. bought a new position in shares of Principal Healthcare Innovators Index ETF during the fourth quarter worth approximately $91,000. Bank Julius Baer & Co. Ltd Zurich bought a new position in shares of Principal Healthcare Innovators Index ETF during the fourth quarter worth approximately $117,000. Finally, PSI Advisors LLC bought a new position in shares of Principal Healthcare Innovators Index ETF during the fourth quarter worth approximately $265,000.

NASDAQ:BTEC opened at $56.09 on Tuesday. The stock’s 50 day moving average price is $59.49 and its two-hundred day moving average price is $59.82. Principal Healthcare Innovators Index ETF has a 12-month low of $33.19 and a 12-month high of $73.38.

Featured Story: How to Invest in Stocks with Increasing Dividends

Receive News & Ratings for Principal Healthcare Innovators Index ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Principal Healthcare Innovators Index ETF and related companies with MarketBeat.com's FREE daily email newsletter.